Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

H.R. 1796 would establish or expand federal initiatives focused on sickle cell disease and other inherited blood disorders. Based on the bill's policy area and subjects, the legislation would likely authorize funding for medical research into these conditions, create surveillance systems to track their prevalence and outcomes, support prevention and health promotion efforts, and improve access to treatment options. If enacted, the bill could increase federal resources dedicated to understanding and managing these diseases, potentially leading to better diagnostic tools, therapies, and public health monitoring. The bill is currently in the committee review stage and has not yet been voted on by the full House.